% | $
Quotes you view appear here for quick access.

Ampio Pharmaceuticals, Inc. Message Board

  • racavalli racavalli Jun 17, 2013 3:48 PM Flag

    Deck stacked in favor of AMPE

    2 bullish articles today about Ampio, Optina, Ampion, Zertane, ORP, NCE001, NYSE listing today, 2 pivotal trials for 2 blockbusters underway, an imminent announcement of Zertane licensing deal with BIg Pharma, loads of trial data to come, Optina about to unseat Eylea, Ampion will dominate the $65 billion anti-inflammatory market, and other surprises all in store very soon for AMPE.

    What an amazing buying opportunity!!!

    Can't say later that everybody hasn't been advised.

    This is one of the easiest one decision stocks in decades. . . . Buy . . .and . . .HOLD . . . and become very very wealthy.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • 2 Bullish articles about Ampio? Where? Is this something you invented up?

    • " 2 pivotal trials for 2 blockbusters underway"

      Which 2 pivotal trials are those? AMPE has specifically said the scampion study is " a dose-escalation run-in study to a Phase III pivotal trial". What part of that do you not get?

      " an imminent announcement of Zertane licensing deal with BIg Pharma" Hpw long have you been saying that?

      In your Seekin gAlpha aricle on 6/29/12 you wrote "With three blockbuster drugs lined up for quick FDA approvals (much less than one year)"

      Well, it's almost a year, how many of those 3 blockbuster drugs are approved?

      No wonder AMPE didn't hire you.

0.74-0.02(-2.79%)4:00 PMEDT